Kymera Therapeutics, Inc. (KYMR)
$112.40+2.84%Close
SELLBEAR · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.2B
- Beta
- 1.98
- P/E (TTM)
- -32.61
- Short % float
- 13.59%
- Days to cover
- 12.0
- SI change
- -5.9%
- 1W
- +4.67%
- 1M
- -3.93%
- vs SPY 1W
- +3.50%
- vs SPY 1M
- -6.92%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KYMR?
- LOPJLB’s latest quantitative signal on Kymera Therapeutics, Inc. (KYMR) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is KYMR in?
- Kymera Therapeutics, Inc. (KYMR) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Kymera Therapeutics, Inc. (KYMR) do?
- Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which …